Supplemental Figure 2 from Dynamics of Mutant Hematopoietic Progenitor Cells Are Not Associated with Clinical Outcomes in Multiple Myeloma
Camila Guerrero, María José Larráyoz, Irache Erdozain, Noemí Puig et autres
0 citations
María José Larráyoz
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
138Publications signalées
2178Citations signalées
2Affiliations récentes
Les institutions déclarées
Les domaines associés
Acute Myeloid Leukemia ResearchMyeloproliferative Neoplasms: Diagnosis and TreatmentMultiple Myeloma Research and TreatmentsChronic Lymphocytic Leukemia ResearchChronic Myeloid Leukemia Treatments
Les publications récentes
Supplemental Table 7 from Dynamics of Mutant Hematopoietic Progenitor Cells Are Not Associated with Clinical Outcomes in Multiple Myeloma
Camila Guerrero, María José Larráyoz, Irache Erdozain, Noemí Puig et autres
0 citations
Supplemental Table 4 from Dynamics of Mutant Hematopoietic Progenitor Cells Are Not Associated with Clinical Outcomes in Multiple Myeloma
Camila Guerrero, María José Larráyoz, Irache Erdozain, Noemí Puig et autres
0 citations
Supplemental Table 6 from Dynamics of Mutant Hematopoietic Progenitor Cells Are Not Associated with Clinical Outcomes in Multiple Myeloma
Camila Guerrero, María José Larráyoz, Irache Erdozain, Noemí Puig et autres
0 citations
Supplemental Table 8 from Dynamics of Mutant Hematopoietic Progenitor Cells Are Not Associated with Clinical Outcomes in Multiple Myeloma
Camila Guerrero, María José Larráyoz, Irache Erdozain, Noemí Puig et autres
0 citations
Supplemental Figure 1 from Dynamics of Mutant Hematopoietic Progenitor Cells Are Not Associated with Clinical Outcomes in Multiple Myeloma
Camila Guerrero, María José Larráyoz, Irache Erdozain, Noemí Puig et autres
0 citations
Supplemental Table 2 from Dynamics of Mutant Hematopoietic Progenitor Cells Are Not Associated with Clinical Outcomes in Multiple Myeloma
Camila Guerrero, María José Larráyoz, Irache Erdozain, Noemí Puig et autres
0 citations
Supplemental Table 9 from Dynamics of Mutant Hematopoietic Progenitor Cells Are Not Associated with Clinical Outcomes in Multiple Myeloma
Camila Guerrero, María José Larráyoz, Irache Erdozain, Noemí Puig et autres
0 citations
Supplemental Table 1 from Dynamics of Mutant Hematopoietic Progenitor Cells Are Not Associated with Clinical Outcomes in Multiple Myeloma
Camila Guerrero, María José Larráyoz, Irache Erdozain, Noemí Puig et autres
0 citations
Supplemental Table 3 from Dynamics of Mutant Hematopoietic Progenitor Cells Are Not Associated with Clinical Outcomes in Multiple Myeloma
Camila Guerrero, María José Larráyoz, Irache Erdozain, Noemí Puig et autres
0 citations
Supplemental Table 5 from Dynamics of Mutant Hematopoietic Progenitor Cells Are Not Associated with Clinical Outcomes in Multiple Myeloma
Camila Guerrero, María José Larráyoz, Irache Erdozain, Noemí Puig et autres
0 citations
Validation of ELN 2024 genetic classification in patients with AML treated with HMA-based regimens: PETHEMA registry study
Eva Barragán, José Vicente Gil, Rosa Ayala, Carmen Chillón et autres
es, gb (code pays fourni par la source)
0 citations
Blood Neoplasia
BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.